|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC,
Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, et al: Prognostic
nomogram for refining the prognostication of the proposed 8th
edition of the AJCC/UICC staging system for nasopharyngeal cancer
in the era of intensity-modulated radiotherapy. Cancer.
122:3307–3315. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hui EP, Leung SF, Au JS, Zee B, Tung S,
Chua D, Sze WM, Law CK, Leung TW and Chan AT: Lung metastasis alone
in nasopharyngeal carcinoma: A relatively favorable prognostic
group. A study by the Hong Kong nasopharyngeal carcinoma study
group. Cancer. 101:300–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng WT, Yuen KT, Au KH, Chan OS and Lee AW:
Staging of nasopharyngeal carcinoma-the past, the present and the
future. Oral Oncol. 50:549–554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin JC, Chen KY, Wang WY, Jan JS, Liang
WM, Tsai CS and Wei YH: Detection of Epstein-Barr virus DNA in the
peripheral-blood cells of patients with nasopharyngeal carcinoma:
Relationship to distant metastasis and survival. J Clin Oncol.
19:2607–2615. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou GQ, Tang LL, Mao YP, Chen L, Li WF,
Sun Y, Liu LZ, Li L, Lin AH and Ma J: Baseline serum lactate
dehydrogenase levels for patients treated with intensity-modulated
radiotherapy for nasopharyngeal carcinoma: A predictor of poor
prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol
Phys. 82:e359–e365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv X, Xiang YQ, Cao SM, Qian CN, Li NW,
Guo L, Mai HQ, Chen QY, Huang PY, Luo D, et al: Prospective
validation of the prognostic value of elevated serum vascular
endothelial growth factor in patients with nasopharyngeal
carcinoma: More distant metastases and shorter overall survival
after treatment. Head Neck. 33:780–785. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang XR, Li YQ, Liang SB, Jiang W, Liu F,
Ge WX, Tang LL, Mao YP, He QM, Yang XJ, et al: Development and
validation of a gene expression-based signature to predict distant
metastasis in locoregionally advanced nasopharyngeal carcinoma: A
retrospective, multicentre, cohort study. Lancet Oncol. 19:382–393.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goretti E, Wagner DR and Devaux Y: miRNAs
as biomarkers of myocardial infarction: A step forward towards
personalized medicine? Trends Mol Med. 20:716–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng Z, Wang Y, Fang X, Yan F, Pan H, Gu
L, Xie C, Li Y, Hu Y, Cao Y and Tang Z: Research on miRNA-195 and
target gene CDK6 in oral verrucous carcinoma. Cancer Gene Ther.
24:282–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He B, Li W, Wu Y, Wei F, Gong Z, Bo H,
Wang Y, Li X, Xiang B, Guo C, et al: Epstein-Barr virus-encoded
miR-BART6-3p inhibits cancer cell metastasis and invasion by
targeting long non-coding RNA LOC553103. Cell Death Dis.
7:e23532016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watanabe A, Tagawa H, Yamashita J, Teshima
K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T,
et al: The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saito Y, Suzuki H, Imaeda H, Matsuzaki J,
Hirata K, Tsugawa H, Hibino S, Kanai Y, Saito H and Hibi T: The
tumor suppressor microRNA-29c is downregulated and restored by
celecoxib in human gastric cancer cells. Int J Cancer.
132:1751–1760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee KT, Tan JK, Lam AK and Gan SY:
MicroRNAs serving as potential biomarkers and therapeutic targets
in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol
Hematol. 103:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei
RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al: Prognostic value of a
microRNA signature in nasopharyngeal carcinoma: A microRNA
expression analysis. Lancet Oncol. 13:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sengupta S, den Boon JA, Chen IH, Newton
MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, et
al: Genome-wide expression profiling reveals EBV-associated
inhibition of MHC class I expression in nasopharyngeal carcinoma.
Cancer Res. 66:7999–8006. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Horvath S and Dong J: Geometric
interpretation of gene coexpression network analysis. PLoS Comput
Biol. 4:e10001172008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang JH, Li JH, Shao P, Zhou H, Chen YQ
and Qu LH: starBase: A database for exploring microRNA-mRNA
interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.
Nucleic Acids Res. 39((Database Issue)): D202–D209. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dennis G, Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43((Database Issue)): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu SL, Chen HY, Chang GC, Chen CY, Chen
HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lossos IS, Czerwinski DK, Alizadeh AA,
Wechser MA, Tibshirani R, Botstein D and Levy R: Prediction of
survival in diffuse large-B-cell lymphoma based on the expression
of six genes. N Engl J Med. 350:1828–1837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ji J, Shi J, Budhu A, Yu Z, Forgues M,
Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z and Rana TM: Therapeutic targeting of
microRNAs: Current status and future challenges. Nat Rev Drug
Discov. 13:622–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu JQ, Yi HM, Ye X, Zhu JF, Yi H, Li LN,
Xiao T, Yuan L, Li JY, Wang YY, et al: miRNA-203 reduces
nasopharyngeal carcinoma radioresistance by targeting IL8/AKT
signaling. Mol Cancer Ther. 14:2653–2664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cvitkovic E, Bachouchi M, Boussen H,
Busson P, Rousselet G, Mahjoubi R, Flores P, Tursz T, Armand JP and
Azli N: Leukemoid reaction, bone marrow invasion, fever of unknown
origin, and metastatic pattern in the natural history of advanced
undifferentiated carcinoma of nasopharyngeal type: A review of 255
consecutive cases. J Clin Oncol. 11:2434–2442. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Teo PM, Kwan WH, Lee WY, Leung SF and
Johnson PJ: Prognosticators determining survival subsequent to
distant metastasis from nasopharyngeal carcinoma. Cancer.
77:2423–2431. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sengupta S, den Boon JA, Chen IH, Newton
MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B and
Ahlquist P: MicroRNA 29c is down-regulated in nasopharyngeal
carcinomas, up-regulating mRNAs encoding extracellular matrix
proteins. Proc Natl Acad Sci USA. 105:5874–5878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, He Q, Wen X, Hong X, Yang X, Tang X,
Zhang P, Lei Y, Sun Y, Zhang J, et al: EZH2-DNMT1-mediated
epigenetic silencing of miR-142-3p promotes metastasis through
targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ.
26:1089–1106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yue PY, Ha WY, Lau CC, Cheung FM, Lee AW,
Ng WT, Ngan RK, Yau CC, Kwong DL, Lung HL, et al: MicroRNA
profiling study reveals miR-150 in association with metastasis in
nasopharyngeal carcinoma. Sci Rep. 7:120122017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y,
Wang X, Zou B, Zhang S, Jing T, et al: miR-29a/b enhances cell
migration and invasion in nasopharyngeal carcinoma progression by
regulating SPARC and COL3A1 gene expression. PLoS One.
10:e01209692015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng Z, Qu JQ, Yi HM, Ye X, Huang W, Xiao
T, Li JY, Wang YY, Feng J, Zhu JF, et al: miR-125b regulates
proliferation and apoptosis of nasopharyngeal carcinoma by
targeting A20/NF-κB signaling pathway. Cell Death Dis. 8:e28552017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan G, Tang X and Tang F: The role of
microRNAs in nasopharyngeal carcinoma. Tumour Biol. 36:69–79. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho WC: MicroRNAs in cancer-from research
to therapy. Biochim Biophys Acta. 1805:209–217. 2010.PubMed/NCBI
|
|
39
|
Zuo LL, Zhang J, Liu LZ, Zhou Q, Du SJ,
Xin SY, Ning ZP, Yang J, Yu HB, Yue WX, et al: Cadherin 6 is
activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis
as an interplay node of multiple pathways in nasopharyngeal
carcinoma. Oncogenesis. 6:4022017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin CW, Li XR, Zhang Y, Hu G, Guo YH, Zhou
JY, Du J, Lv L, Gao K, Zhang Y and Deng H: TAp63 suppress
metastasis via miR-133b in colon cancer cells. Br J Cancer.
110:2310–2320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu H, Lu J, Zuo L, Yan Q, Yu Z, Li X,
Huang J, Zhao L, Tang H, Luo Z, et al: Epstein-Barr virus
downregulates microRNA 203 through the oncoprotein latent membrane
protein 1: A contribution to increased tumor incidence in
epithelial cells. J Virol. 86:3088–3099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peng G, Liao Y and Shen C: miRNA-429
inhibits astrocytoma proliferation and invasion by targeting BMI1.
Pathol Oncol Res. 23:369–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mayo LD and Donner DB: The PTEN, Mdm2, p53
tumor suppressor-oncoprotein network. Trends Biochem Sci.
27:462–467. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stambolic V, MacPherson D, Sas D, Lin Y,
Snow B, Jang Y, Benchimol S and Mak TW: Regulation of PTEN
transcription by p53. Mol Cell. 8:317–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Freeman DJ, Li AG, Wei G, Li HH, Kertesz
N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, et
al: PTEN tumor suppressor regulates p53 protein levels and activity
through phosphatase-dependent and -independent mechanisms. Cancer
Cell. 3:117–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jung SH, Hwang HJ, Kang D, Park HA, Lee
HC, Jeong D, Lee K, Park HJ, Ko YG and Lee JS: mTOR kinase leads to
PTEN-loss-induced cellular senescence by phosphorylating p53.
Oncogene. 38:1639–1650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Andreozzi M, Quagliata L, Gsponer JR, Ruiz
C, Vuaroqueaux V, Eppenberger-Castori S, Tornillo L and Terracciano
LM: VEGFA gene locus analysis across 80 human tumour types reveals
gene amplification in several neoplastic entities. Angiogenesis.
17:519–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen HX, Xu XX, Tan BZ, Zhang Z and Zhou
XD: MicroRNA-29b inhibits angiogenesis by targeting VEGFA through
the MAPK/ERK and PI3K/Akt signaling pathways in endometrial
carcinoma. Cell Physiol Biochem. 41:933–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cheng JZ, Chen JJ, Xue K, Wang ZG and Yu
D: Clinicopathologic and prognostic significance of VEGF, JAK2 and
STAT3 in patients with nasopharyngeal carcinoma. Cancer Cell Int.
18:1102018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
